Compare iShares Global Clean Energy ETF (ICLN) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Clean Energy ETF vs GeneDx Holdings Corp — how do they compare? iShares Global Clean Energy ETF trades at $18.43, while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: iShares Global Clean Energy ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| ICLN | WGS | |
|---|---|---|
52-Week High | $23.75 | $167.51 |
52-Week Low | $13.66 | $34.51 |
Market Cap | — | $2.44B |
Sector | — | Technology |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICLN, the iShares Global Clean Energy ETF, trades at $18.41, up 1.83% today, but technical indicators signal a bearish trend with moving averages and overall momentum pointing lower. The fund provides exposure to 105 global renewable energy companies, though key valuation and profitability ratios are not publicly disclosed for the ETF itself. Recent news highlights strong 2026 performance with over 25% gains, driven by global energy security concerns and data center power demand, though it faces competition from traditional energy ETFs offering lower fees and higher yields.
The outlook for ICLN is mixed; clean energy tailwinds from policy support and electrification trends offer growth potential, but risks include regulatory hurdles, fee competitiveness, and volatility. Analyst sentiment is cautious due to fee comparisons and policy dependence, with institutional interest balanced against outperformance of alternatives like uranium ETFs. Investment suitability hinges on appetite for clean energy sector volatility versus stable income.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
